Sierra Ocean’s Orchestra BioMed OBIO Stock Holding History

Sierra Ocean’s Portfolio OBIO Stock Details OBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-119	Closed	-$319	–	664
2025 Q2	$319	Hold	119	–	–	﹤0.01%	1018
2025 Q1	$509	Hold	119	–	–	﹤0.01%	1020
2024 Q4	$476	Buy	+119	New	+$639	﹤0.01%	1016

Other funds holding OBIO

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sierra Ocean's OBIO Position: Q3 2025 in Review

Sierra Ocean sold out of Orchestra BioMed (OBIO) in Q3 2025, closing a stake of 119 shares — an estimated $319 sold.

Sierra Ocean first reported a position in OBIO in Q4 2024 and held it in 3 quarters. The position peaked at $509 in Q1 2025. 52 funds tracked by Wall St. Rank hold OBIO as of Q3 2025.

Sierra Ocean reported no remaining Orchestra BioMed position as of Q3 2025 after selling out during the quarter.
Sierra Ocean sold 119 Orchestra BioMed shares in Q3 2025, an estimated $319.
Sierra Ocean first reported a position in Orchestra BioMed in Q4 2024 and held it in 3 quarters.
Sierra Ocean's Orchestra BioMed position peaked at $509 in Q1 2025.
52 funds tracked by Wall St. Rank held Orchestra BioMed as of Q3 2025.

Based on Sierra Ocean's 13F filing for Q3 2025, filed 7 Nov 2025.